A case for APRIL/BLyS directed therapy not eosinophil directed therapy for alloantibody elimination (Q46500263)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 December 2013

Language	Label	Description	Also known as
English	A case for APRIL/BLyS directed therapy not eosinophil directed therapy for alloantibody elimination	scientific article published on 9 December 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24320568

A case for APRIL/BLyS directed therapy not eosinophil directed therapy for alloantibody elimination (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24320568

author name string

R R Redfield

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24320568

P L Abt

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24320568

A Naji

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24320568

language of work or name

0 references

publication date

9 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24320568

American Journal of Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24320568

14

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24320568

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24320568

492-493

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24320568

Eosinophils are not required for the induction and maintenance of an alloantibody response

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12576

21 January 2018

Eosinophils are required for the maintenance of plasma cells in the bone marrow

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12576

21 January 2018

Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12576

21 January 2018

Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12576

21 January 2018

Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12576

21 January 2018

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12576

21 January 2018

Anti-IL5 decreases the number of eosinophils but not the severity of dermatitis in Sharpin-deficient mice

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12576

21 January 2018

Essential role for B cells in transplantation tolerance.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12576

21 January 2018

Identifiers

10.1111/AJT.12576

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24320568

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/24320568

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46500263&oldid=2114465565"